인쇄하기
취소

Boryung Pharmaceutical and Roche will co-promote the hepatitis type B and C treatment ‘Pegasys’

Published: 2014-12-31 13:29:29
Updated: 2014-12-31 13:29:29

Boryung Pharmaceutical and Roche Korea will co-promote the chronic hepatitis type B and C treatment ‘Pegasys’.

Boryung Pharmaceutical (CEO Tae-hong Choi) and Roche Korea (General Manager Mike Crichton) announced on the 29th that they have made a co-promotion contract for the chronic hepatitis type B and C ‘Pegasys’.

The two companies will work on sales and marketing under the co-promotion con...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.